XML 48 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
BUSINESS ACQUISITIONS
9 Months Ended
Sep. 30, 2012
Business Combinations [Abstract]  
BUSINESS ACQUISITIONS
BUSINESS ACQUISITIONS
Ascension Orthopedics, Inc.
On September 23, 2011, the Company acquired Ascension Orthopedics, Inc. (“Ascension”) for $66.0 million, which includes amounts paid for working capital adjustments of $0.2 million less amounts received from escrow of $0.7 million. Ascension, based in Austin, Texas, develops and distributes a range of implants for the shoulder, elbow, wrist, hand, foot and ankle.
The following summarizes the final allocation of the purchase price based on fair value of the assets acquired and liabilities assumed:
 
 
Final
Purchase Price
Allocation
 
 
 
(Dollars in thousands)
 
 
Cash
$
627

 
 
Inventory
12,760

 
 
Accounts receivable
2,917

 
 
Other current assets
2,398

 
 
Property, plant and equipment
4,649

 
 
Other long-term assets
70

 
 
Deferred tax asset — long term
12,543

 
 
Intangible assets
 
 
Wtd. Avg. Life:
Technology
7,885

 
10 years
Customer relationships
5,750

 
12 years
In-process research and development
1,739

 
Indefinite
Supplier relationship
4,510

 
10 years
Trade name
560

 
1 year
Goodwill
15,460

 
 
Total assets acquired
71,868

 
 
Accounts payable and other liabilities
5,827

 
 
Net assets acquired
$
66,041

 
 


Management determined the preliminary fair value of net assets acquired during the third quarter of 2011 and finalized the working capital adjustment in the second quarter of 2012. Measurement period adjustments included above reflected a decrease in the total fair value of inventory acquired and a decrease in the value of long-term deferred tax assets acquired which was recorded in the fourth quarter of 2011. The measurement period adjustments were made to reflect facts and circumstances existing as of the acquisition date, and did not result from intervening events subsequent to the acquisition date. These adjustments did not have a significant impact on the Company’s previously reported consolidated financial statements and, therefore, the Company has not retrospectively adjusted those financial statements.
The goodwill recorded in connection with this acquisition is based on (i) expected cost savings, operating synergies and other benefits expected to result from the combined operations, (ii) the value of the going-concern element of Ascension’s existing business (that is, the higher rate of return on the assembled net assets versus if the Company had acquired all of the net assets separately), and (iii) intangible assets that do not qualify for separate recognition such as Ascension’s assembled workforce. The goodwill acquired will not be deductible for tax purposes.
SeaSpine, Inc.
On May 23, 2011, the Company acquired all of the outstanding common stock of SeaSpine, Inc. (“SeaSpine”) for $89.0 million, less working capital adjustments of $0.3 million and indemnification holdbacks totaling $7.4 million of which $4.9 million remains accrued at September 30, 2012. SeaSpine is based in Vista, California and designs, develops and manufactures spinal fixation products and synthetic bone substitute products.
The following summarizes the final allocation of the purchase price based on fair value of the assets acquired and liabilities assumed:
 
 
Final
Purchase Price
Allocation
 
 
 
(Dollars in thousands)
 
 
Cash
$
201

 
 
Inventory
14,900

 
 
Accounts receivable
7,608

 
 
Other current assets
623

 
 
Property, plant and equipment
9,177

 
 
Deferred tax asset—long term
302

 
 
Intangible assets:
 
 
Wtd. Avg. Life:
Technology
3,000

 
8 years
Customer relationships
41,200

 
13 years
Non-compete agreements
1,900

 
4 years
Trade name
300

 
1 year
Goodwill
14,572

 
 
Total assets acquired
93,783

 
 
Accounts payable and other liabilities
5,108

 
 
Net assets acquired
$
88,675

 
 


Management determined the preliminary fair value of net assets acquired during the second quarter of 2011 and finalized the working capital adjustment in the first quarter of 2012. Measurement period adjustments included above reflect a decrease in the total fair value of consideration to be transferred pursuant to the final working capital adjustment. These measurement period adjustments were made to reflect facts and circumstances existing as of the acquisition date, and did not result from intervening events subsequent to the acquisition date. This adjustment did not have a significant impact on the Company’s previously reported consolidated financial statements and, therefore, the Company has not retrospectively adjusted those financial statements.
The goodwill recorded in connection with this acquisition is based on the benefits the Company expects to generate from SeaSpine’s future cash flows. For tax purposes, the Company is treating the acquisition as an asset acquisition; therefore, the goodwill will be deductible for tax purposes.
Pro Forma Results
The following unaudited pro forma financial information summarizes the results of operations for the three and nine months ended September 30, 2011 as if the acquisitions completed by the Company during 2011 had been completed as of January 1, 2010. The pro forma results are based upon certain assumptions and estimates, and they give effect to actual operating results prior to the acquisitions and adjustments to reflect (i) increased interest expense, depreciation expense, intangible asset amortization and fair value inventory step-up, (ii) decreases in certain expenses that will not be recurring in the post-acquisition entity, and (iii) income taxes at a rate consistent with the Company’s statutory rate. No effect has been given to other cost reductions or operating synergies. As a result, these pro forma results do not necessarily represent results that would have occurred if the acquisitions had taken place on the basis assumed above, nor are they indicative of the results of future combined operations.
 
 
Three Months Ended 
 
Nine Months Ended
 
September 30,
2011
 
September 30,
2011
 
(in thousands except per share amounts)
Total Revenue
$
206,048

 
$
608,375

Net income
$
9,416

 
$
17,690

Net income per share
 
 
 
Basic
$
0.33

 
$
0.61

Diluted
$
0.32

 
$
0.59